ClinicalTrials.Veeva

Menu

Defining PET / CT Protocols With Optimized F18-FDG (Fluorodeoxyglucose) Dose, Focusing on Reduced Radiation Dose and Improved Image Quality (pet-ct)

H

Hospital Sao Rafael

Status

Completed

Conditions

Secondary Neoplasm Malignant and Unspecified Lymph Nodes
Malignant Neoplasm of Bronchus and Lung
Non-Hodgkin Lymphoma, Follicular (Nodular)
Hodgkin Disease
Malignant Neoplasm of Colon
Malignant Neoplasm of Small Intestine
Malignant Neoplasm of Breast
Malignant Melanoma of the Skin

Treatments

Other: Image quantify

Study type

Observational

Funder types

Other

Identifiers

NCT02378337
27558714.4.0000.0048

Details and patient eligibility

About

Identify the best combination of predictive variables that influence ionizing radiation dose and improved image quality through analysis and quantification of PET-CT images in simulators and patients.

Enrollment

335 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Healthy volunteers;
  • Both genders;
  • Age over 18 years;
  • Clinical indication for PET-CT scan.

Exclusion criteria

  • Pregnant women;
  • Patients who have lesions in the liver metabolically active whether primary or metastatic;
  • Patients with movement difficulties.

Trial design

335 participants in 2 patient groups

Retrospective development cohort
Description:
A total of 85 18F-FDG-PET adult studies were gathered over a 3-month period and retrospectively evaluated.
Treatment:
Other: Image quantify
Prospective validation cohort
Description:
To verify the application of methodology in clinical routine, we conducted a second phase of the study prospectively in 250 subjects (phase 2) using inclusion and exclusion criteria of the retrospective study (phase 1).
Treatment:
Other: Image quantify

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems